京都大学 恩田佳幸 Therapeutic Advances in Hematology

Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and
carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: A multicenter retrospective analysis

タイトルとURLをコピーしました